Results 131 to 140 of about 13,238 (216)

Navigating the Transition to RNA-Based Influenza Vaccines: A State-of-the-Art Review. [PDF]

open access: yesVaccines (Basel)
Panagiotopoulos AP   +7 more
europepmc   +1 more source

Development of mRNA vaccines against herpes zoster. [PDF]

open access: yesHum Vaccin Immunother
Li D   +9 more
europepmc   +1 more source

Cutaneous Events After Recombinant Zoster Vaccination and Shoulder Injury Related to Zoster Vaccine Administration: A Narrative Review. [PDF]

open access: yesJ Clin Med
Ciccullo C   +10 more
europepmc   +1 more source

mRNA-1010 and the Future of Seasonal Influenza Prevention: Towards Next-Generation Respiratory Vaccination. [PDF]

open access: yesVaccines (Basel)
Panagiotopoulos AP   +4 more
europepmc   +1 more source

Long-term Immunogenicity and Safety Profile of the Adjuvanted RSVPreF3 Vaccine in Korean Older Adults: A Sub-analysis of a Phase 3 Trial. [PDF]

open access: yesInfect Chemother
Park SB   +8 more
europepmc   +1 more source

Editorial: Non-reactogenic vaccines against Q-fever

open access: yesFrontiers in Immunology, 2023
Anthony E. Gregory, D. Huw Davies
openaire   +3 more sources

Immunogenicity and Safety of the Adjuvanted Respiratory Syncytial Virus Prefusion F Protein-Based Vaccine When Co-administered With the Adjuvanted Recombinant Herpes Zoster Subunit Vaccine in Adults ≥ 50 Years of Age. [PDF]

open access: yesClin Infect Dis
Roussy JF   +14 more
europepmc   +1 more source

The reactogenicity of rubella vaccine in a population of United Kingdom schoolgirls

open access: yesInternational Journal of Clinical Practice, 1986
M, Poyner   +3 more
openaire   +2 more sources

Immunogenicity and Safety of Coadministration of AS01E-Adjuvanted Respiratory Syncytial Virus Prefusion F Protein Vaccine and a COVID-19 mRNA Vaccine in Adult s Aged ≥50 Years: A Phase 3, Randomized, Noninferiority Trial. [PDF]

open access: yesClin Infect Dis
Bonten M   +13 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy